A Case Report of COVID‐19 With Tracheobronchial Aspergillosis
The concurrence of COVID-19 and tracheobronchial aspergillosis (TBA) is rarely documented in clinical practice. This report presents a case of TBA in a patient diagnosed with COVID-19 prior to the administration of immunosuppressive agents. This case underscores the necessity of considering fungal infections in patients with COVID-19, even during the early stages of the disease. The combination of timely bronchoscopy, antiviral therapy, and antifungal treatment resulted in favorable therapeutic outcomes for the patient.
Authors
- Haolei Liu (ORCID: https://orcid.org/0000-0003-4345-980X)
- Shanshan Wu (ORCID: https://orcid.org/0009-0007-9695-8051)
- Hui Gao
- Junyan Feng
- Hailu Jiao
Institutions
- First Affiliated Hospital of Hunan University of Traditional Chinese Medicine (CN)
- Hunan Academy of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Case Reports in Infectious Diseases
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1155/crdi/4627040
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00